Researchers at Erasmus University Medical Center have identified a blood-based biomarker that can predict the progression rate of Parkinson’s disease. The biomarker, a measurable indicator of the condition, is associated with defects in DNA…

Researchers at Erasmus University Medical Center have identified a blood-based biomarker that can predict the progression rate of Parkinson’s disease. The biomarker, a measurable indicator of the condition, is associated with defects in DNA…